Labcorp to buy Opko unit’s cancer test assets for up to $225M
Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth testing areas.
Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth testing areas.
